Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
AMAG Pharmaceuticals
Pharma
Covis granted FDA hearing over premature-birth med Makena
Covis Pharma was granted an FDA hearing to discuss the potential marketing withdrawal of its controversial premature-birth med Makena.
Noah Higgins-Dunn
Aug 20, 2021 11:19am
The top 10 drugs losing U.S. exclusivity in 2021
Mar 9, 2021 3:00am
FDA experts vote to pull AMAG's premature-birth med Makena
Oct 30, 2019 10:30am
Activist investor calls for new board after Progenics merger try
Oct 10, 2019 10:10am
AMAG bails on proxy fight with settlement for 2 board seats
Oct 8, 2019 9:33am
FDA review of troubled drug could hobble AMAG in proxy fight
Sep 26, 2019 11:54am
